Community Pharmacy Practice in Italy during the COVID-19 (SARS-CoV-2) Pandemic: Regulatory Changes and a Cross-Sectional Analysis of Seroprevalence

Pharmacists in the community and the essential requirement to safeguard their own health have become fundamental since the spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The aims of this paper were (I) to analyze the directives provided to pharmacists in 2020 regarding preventative safety measures to be adopted; (II) to determine the number of pharmacists who came into contact with SARS-CoV-2 in North-West Italy and relate this to the adopted preventative measures. The first aim was pursued by conducting a bibliographic research, consulting the principal regulatory sources. The second one was achieved with an observational study by administering a questionnaire and performing a serological test. The various protection measures imposed by national and regional legislation were analyzed. Two hundred and eighty-six pharmacists (about 8% of the invited ones) responded to the survey. Ten pharmacists reported a positive result to the serological test. Of the subjects who presented a positive result, three declared that they had not used a hand sanitizer, while two stated that they had not scheduled the cleaning and decontamination of surfaces. Two interviewees had not set up a system of quota restrictions on admissions. In four cases, a certified cleaning company had decontaminated the premises. The results of our study show that during the coronavirus disease 2019 (COVID-19) pandemic, the most pressing challenge for community pharmacists has been the protection of staff and clients inside the pharmacy; the challenge to be faced in the near future will probably be the management of new responsibilities..

Medienart:

E-Artikel

Erscheinungsjahr:

2021

Erschienen:

2021

Enthalten in:

Zur Gesamtaufnahme - volume:18

Enthalten in:

International Journal of Environmental Research and Public Health - 18(2021), 2302, p 2302

Sprache:

Englisch

Beteiligte Personen:

Francesca Baratta [VerfasserIn]
Giulio Mario Visentin [VerfasserIn]
Lorenzo Ravetto Enri [VerfasserIn]
Marco Parente [VerfasserIn]
Irene Pignata [VerfasserIn]
Francesco Venuti [VerfasserIn]
Giovanni Di Perri [VerfasserIn]
Paola Brusa [VerfasserIn]

Links:

doi.org [kostenfrei]
doaj.org [kostenfrei]
www.mdpi.com [kostenfrei]
Journal toc [kostenfrei]
Journal toc [kostenfrei]

Themen:

COVID-19
Community pharmacies
Italy
Medicine
Pharmacists
R
SARS-CoV-2
Seroprevalence

doi:

10.3390/ijerph18052302

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

DOAJ016256069